Zobrazeno 1 - 10
of 1 752
pro vyhledávání: '"response durability"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cortese M; Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Stanford, CA, USA., Hagan T; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Rouphael N; Hope Clinic of the Emory Vaccine Center, Decatur, GA, USA., Wu SY; Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Stanford, CA, USA., Xie X; Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Stanford, CA, USA., Kazmin D; Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Stanford, CA, USA., Wimmers F; Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Stanford, CA, USA., Gupta S; Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA., van der Most R; GSK, Rixensart, Belgium., Coccia M; GSK, Rixensart, Belgium., Aranuchalam PS; Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Stanford, CA, USA., Nakaya HI; Hospital Israelita Albert Einstein, São Paulo, Brazil., Wang Y; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Coyle E; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Horiuchi S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Wu H; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Bower M; Hope Clinic of the Emory Vaccine Center, Decatur, GA, USA., Mehta A; Hope Clinic of the Emory Vaccine Center, Decatur, GA, USA., Gunthel C; Hope Clinic of the Emory Vaccine Center, Decatur, GA, USA., Bosinger SE; Emory Vaccine Center, Yerkes National Primate Research Center, Atlanta, GA, USA.; Yerkes Genomics Core Laboratory, Yerkes National Primate Research Center, Atlanta, GA, USA.; Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA., Kotliarov Y; NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD, USA., Cheung F; NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD, USA., Schwartzberg PL; NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD, USA.; Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, MD, USA., Germain RN; NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD, USA.; Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, MD, USA., Tsang J; NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD, USA.; Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, MD, USA., Li S; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Albrecht R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Ueno H; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Immunology, Kyoto University, Kyoto, Japan., Subramaniam S; Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA., Mulligan MJ; Division of Infectious Diseases and Immunology, Department of Medicine and NYU Langone Vaccine Center, NYU Grossman School of Medicine, New York, NY, USA., Khurana S; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Golding H; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Pulendran B; Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Stanford, CA, USA. bpulend@stanford.edu.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. bpulend@stanford.edu.; Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, USA. bpulend@stanford.edu.
Publikováno v:
Nature immunology [Nat Immunol] 2025 Jan; Vol. 26 (1), pp. 116-130. Date of Electronic Publication: 2025 Jan 02.
Autor:
Brunner, Wendy M., Freilich, Daniel, Victory, Jennifer, Krupa, Nicole, Scribani, Melissa B., Jenkins, Paul, Lasher, Emily G., Fink, Amanda, Shah, Anshini, Cross, Peggy, Bush, Valerie, Peek, Laura J., Pestano, Gary A., Gadomski, Anne M.
Publikováno v:
In International Journal of Infectious Diseases October 2022 123:183-191
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wendy M. Brunner, Daniel Freilich, Jennifer Victory, Nicole Krupa, Melissa B. Scribani, Paul Jenkins, Emily G. Lasher, Amanda Fink, Anshini Shah, Peggy Cross, Valerie Bush, Laura J. Peek, Gary A. Pestano, Anne M. Gadomski
Publikováno v:
International Journal of Infectious Diseases, Vol 123, Iss , Pp 183-191 (2022)
Objectives: There are limited comparative immunologic durability data post COVID-19 vaccinations. Methods: Approximately 8.4 months after primary COVID-19 vaccination, 647 healthcare workers completed surveys about COVID-19 vaccinations/infections an
Externí odkaz:
https://doaj.org/article/ed91147126304a4dbb01e0e7701eee16
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Piotr Eder, Maria Kłopocka, Halina Cichoż-Lach, Renata Talar-Wojnarowska, Maria Kopertowska-Majchrzak, Agata Michalak, Rafał Filip, Katarzyna Waszak, Kamila Stawczyk-Eder, Maria Janiak, Krzysztof Skrobot, Ariel Liebert, Hubert Zatorski, Anna Solarska-Półchłopek, Michał Krogulecki, Anna Pękała, Elżbieta Poniewierka, Izabela Smoła, Aleksandra Kaczka, Krzysztof Wojciechowski, Szymon Drygała, Edyta Zagórowicz
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background: Vedolizumab is a gut-selective anti-lymphocyte trafficking agent used to treat ulcerative colitis (UC) and Crohn’s disease. Objectives: We aimed to evaluate the effectiveness, safety, and durability of the therapeutic effect of vedolizu
Externí odkaz:
https://doaj.org/article/4af6e2e2447947e6be3468a5b721b17e
Autor:
Hazzard, Vivienne M.1 viviennehazzard@gmail.com, Peterson, Carol B.2, Crosby, Ross D.1, Schaefer, Lauren M.1, Smith, Kathryn E.3, Engel, Scott G.1, Crow, Scott J.2,4, Wonderlich, Stephen A.1
Publikováno v:
International Journal of Eating Disorders. Dec2020, Vol. 53 Issue 12, p1918-1927. 10p. 4 Charts.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.